首页 > 最新文献

Archivos de la Sociedad Espanola de Oftalmologia最新文献

英文 中文
Orbital trochleitis: Literature review 眼眶套管炎:文献综述。
Pub Date : 2024-10-01 DOI: 10.1016/j.oftale.2024.06.008
Trochleitis is clinically and/or radiologically evidenced inflammation of the trochlea or orbital pulley.
Clinically it is characterized by pain and hypersensitivity in the superomedial orbital angle, which is increased or triggered by direct palpation of the area and/or eye movements. During the REM (rapid eye movements) phase of sleep, patients with trochleitis suffer from nocturnal micro-awakenings that impede their rest, and pain is often associated with visual symptoms (diplopia or Brown's syndrome).
The lack of common guidelines for diagnosis and treatment of this disease, its low prevalence and the lack of knowledge of the different entities associated with trochlear pain, leads to underdiagnosis or misdiagnosis. It is essential to know the characteristics of this pathology and to diagnose it correctly, differentiating it from other trochlear pain entities, in order to be able to carry out an adequate therapeutic and prognostic approach. The lack of consensus on the therapeutic protocol means that various treatments are used, in different order and often with a combination of several without a firm scientific basis.
This comprehensive review of previous studies concludes that nonsteroidal anti-inflammatory drugs (NSAIDs) achieve an overall complete cure rate of 77%, although this rate decreases to 30% in case of motility restriction or diplopia. Intratrochlear corticosteroid injection achieves an overall complete cure rate of 86%, even in the worst prognosis trochleitis, being the only effective option in NSAID-refractory trochleitis and currently being questioned as the first treatment option.
蝶窦炎是指蝶窦或眶轮在临床和/或放射学上表现出的炎症。临床表现为眶上内角疼痛和过敏,直接触诊该区域和/或眼球运动时疼痛加剧或触发。在快速眼动(REM)睡眠阶段,套管炎患者会出现夜间微觉醒,妨碍其休息,疼痛往往与视觉症状(复视或布朗综合征)有关。由于缺乏诊断和治疗这种疾病的通用指南、发病率低以及对与套管痛相关的不同实体缺乏了解,导致诊断不足或误诊。必须了解这种病症的特征,并正确诊断,将其与其他蹄叶疼痛实体区分开来,这样才能采取适当的治疗和预后方法。由于对治疗方案缺乏共识,因此在没有可靠科学依据的情况下,人们采用了各种不同顺序的治疗方法,而且往往是几种方法的组合。对以往研究的全面回顾得出结论,非甾体类抗炎药(NSAIDs)的总体完全治愈率为 77%,但在运动受限或复视的情况下,治愈率降至 30%。即使是预后最差的套管炎,蜗管内注射皮质类固醇的总体完全治愈率也达到了86%,是非甾体抗炎药难治性套管炎的唯一有效选择,目前作为第一治疗选择受到质疑。
{"title":"Orbital trochleitis: Literature review","authors":"","doi":"10.1016/j.oftale.2024.06.008","DOIUrl":"10.1016/j.oftale.2024.06.008","url":null,"abstract":"<div><div>Trochleitis is clinically and/or radiologically evidenced inflammation of the trochlea or orbital pulley.</div><div>Clinically it is characterized by pain and hypersensitivity in the superomedial orbital angle, which is increased or triggered by direct palpation of the area and/or eye movements. During the REM (rapid eye movements) phase of sleep, patients with trochleitis suffer from nocturnal micro-awakenings that impede their rest, and pain is often associated with visual symptoms (diplopia or Brown's syndrome).</div><div>The lack of common guidelines for diagnosis and treatment of this disease, its low prevalence and the lack of knowledge of the different entities associated with trochlear pain, leads to underdiagnosis or misdiagnosis. It is essential to know the characteristics of this pathology and to diagnose it correctly, differentiating it from other trochlear pain entities, in order to be able to carry out an adequate therapeutic and prognostic approach. The lack of consensus on the therapeutic protocol means that various treatments are used, in different order and often with a combination of several without a firm scientific basis.</div><div>This comprehensive review of previous studies concludes that nonsteroidal anti-inflammatory drugs (NSAIDs) achieve an overall complete cure rate of 77%, although this rate decreases to 30% in case of motility restriction or diplopia. Intratrochlear corticosteroid injection achieves an overall complete cure rate of 86%, even in the worst prognosis trochleitis, being the only effective option in NSAID-refractory trochleitis and currently being questioned as the first treatment option.</div></div>","PeriodicalId":93886,"journal":{"name":"Archivos de la Sociedad Espanola de Oftalmologia","volume":"99 10","pages":"Pages 436-449"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141433583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perception of patients with retinal pathology on aspects of visual function and their management 视网膜病变患者对视觉功能及其管理方面的看法。
Pub Date : 2024-10-01 DOI: 10.1016/j.oftale.2024.06.011

Background and objective

Age-related macular degeneration (AMD) and diabetic retinopathy (DR) are highly prevalent.

Objective

To explore perceptions of patients with AMD or DR about the impact of the disease and treatment on their daily living activities.

Materials and methods

Semi-structured interviews with a questionnaire developed from validated patient reported outcomes questionnaires. The questionnaire consisted of 19 questions about the disease and 9 about the treatment. The questions (items) were answered on a scale from 1 to 9. In addition, the patient interviewed was invited to make free comments on each question. Nine patients with AMD and 9 with DR were interviewed by videoconference or telephone call. A quantitative analysis of the responses and a qualitative analysis of the comments were carried out.

Results

The most relevant item for patients with AMD or DR is “Recognize people when they are nearby”, and “Read text in normal size font in a newspaper or book”, followed, in patients with AMD, by “Do things what you would like” and, in patients with DR, “Feeling frustrated by the vision problems.” Regarding the treatment, the most relevant aspects for both groups is that the treatment works and receiving appropriate information before and after the treatment. The qualitative comments were focused to the disease, the treatment, and to the role of doctors and the health system.

Conclusion

Quantitative responses and free comments can be useful to improve the care of patients with AMD or DR by physicians and the health system.
背景和目的:老年性黄斑变性(AMD)和糖尿病视网膜病变(DR)的发病率很高:探讨老年性黄斑变性或糖尿病视网膜病变患者对疾病和治疗对其日常生活活动的影响的看法:半结构式访谈,问卷由经过验证的患者报告结果问卷编制而成。问卷包括 19 个关于疾病的问题和 9 个关于治疗的问题。这些问题(项目)按 1 到 9 的评分标准进行回答。此外,受访患者还可就每个问题自由发表意见。9 名 AMD 患者和 9 名 DR 患者通过视频会议或电话接受了访谈。对回答进行了定量分析,对评论进行了定性分析:与 AMD 或 DR 患者最相关的项目是 "认出附近的人 "和 "阅读报纸或书籍中正常大小字体的文字",其次是 AMD 患者的 "做自己想做的事 "和 DR 患者的 "因视力问题而感到沮丧"。关于治疗,两组患者最关心的问题都是治疗是否有效,以及在治疗前后是否获得了适当的信息。定性评论的重点是疾病、治疗以及医生和医疗系统的作用:定量回答和自由评论有助于改善医生和医疗系统对老年性视网膜病变(AMD)或动力障碍性视网膜病变(DR)患者的护理。
{"title":"Perception of patients with retinal pathology on aspects of visual function and their management","authors":"","doi":"10.1016/j.oftale.2024.06.011","DOIUrl":"10.1016/j.oftale.2024.06.011","url":null,"abstract":"<div><h3>Background and objective</h3><div>Age-related macular degeneration (AMD) and diabetic retinopathy (DR) are highly prevalent.</div></div><div><h3>Objective</h3><div>To explore perceptions of patients with AMD or DR about the impact of the disease and treatment on their daily living activities.</div></div><div><h3>Materials and methods</h3><div>Semi-structured interviews with a questionnaire developed from validated patient reported outcomes questionnaires. The questionnaire consisted of 19 questions about the disease and 9 about the treatment. The questions (items) were answered on a scale from 1 to 9. In addition, the patient interviewed was invited to make free comments on each question. Nine patients with AMD and 9 with DR were interviewed by videoconference or telephone call. A quantitative analysis of the responses and a qualitative analysis of the comments were carried out.</div></div><div><h3>Results</h3><div>The most relevant item for patients with AMD or DR is “Recognize people when they are nearby”, and “Read text in normal size font in a newspaper or book”, followed, in patients with AMD, by “Do things what you would like” and, in patients with DR, “Feeling frustrated by the vision problems.” Regarding the treatment, the most relevant aspects for both groups is that the treatment works and receiving appropriate information before and after the treatment. The qualitative comments were focused to the disease, the treatment, and to the role of doctors and the health system.</div></div><div><h3>Conclusion</h3><div>Quantitative responses and free comments can be useful to improve the care of patients with AMD or DR by physicians and the health system.</div></div>","PeriodicalId":93886,"journal":{"name":"Archivos de la Sociedad Espanola de Oftalmologia","volume":"99 10","pages":"Pages 427-435"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PHOMS: An apt and accurate acronym PHOMS:一个恰当而准确的缩写。
Pub Date : 2024-10-01 DOI: 10.1016/j.oftale.2024.06.012
{"title":"PHOMS: An apt and accurate acronym","authors":"","doi":"10.1016/j.oftale.2024.06.012","DOIUrl":"10.1016/j.oftale.2024.06.012","url":null,"abstract":"","PeriodicalId":93886,"journal":{"name":"Archivos de la Sociedad Espanola de Oftalmologia","volume":"99 10","pages":"Pages 464-466"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of intraocular lens power formulas in patients with average keratometry greater than 46 diopters 平均角膜度数大于 46 度的患者眼内晶状体功率公式的准确性。
Pub Date : 2024-10-01 DOI: 10.1016/j.oftale.2024.07.006
H. Rodríguez Ortiz , L. Flores Ortiz , R. Devereux García , C. Palacio Pastrana , M. Hilario Pérez , G. Villanueva Pérez , J.M. Piña Valdez , G.Y. Montalvo Domínguez , L.P. Gutierrez Díaz

Objective

To compare the accuracy of Kane, Barrett Universal II, Haigis, and SRK-T formulas in eyes with average keratometry greater than 46 diopters (D).

Methods

A retrospective analysis was conducted on 101 eyes of 101 patients with average keratometry greater than 46 D. The absolute prediction error (EA) was obtained for each patient one month after surgery. The mean absolute prediction error (MEA), median absolute prediction error (MedEA) and the percentage of patients with absolute refractive error less than 0.25 D, 0.50 D, and 1.00 D were calculated for each formula analyzed.

Results

The Kane formula achieved the lowest MEA (0.53 ± 0.43) and the lowest MedEA (0.41), followed by Barrett Universal II (MEA: 0.56 ± 0.42, MedEA: 0.49), SRK-T (MEA: 0.59 ± 0.44, MedEA: 0.54), and Haigis (MEA: 0.77 ± 0.47, MedEA: 0.69), showing a significant difference in the results. It was also observed that the Kane formula was the most accurate, with the highest percentage of patients, with EA less than 0.25 D, 0.50 D, and 1.00 D (30.7%, 54.4%, and 86.1%, respectively), while the Haigis formula was the least accurate (12.9%, 33.7%, and 69.3%, respectively).

Conclusion

In eyes with corneas having average keratometry greater than 46 D, the Kane formula proves to be a useful tool in intraocular lens (IOL) power calculation and demonstrates higher precision compared to the Barrett Universal II, SRK-T, and Haigis formulas.
目的:比较凯恩公式、巴雷特通用 II 公式、海吉斯公式和 SRK-T 公式对平均角膜度数大于 46 度 (D) 眼睛的准确性:比较 Kane、Barrett Universal II、Haigis 和 SRK-T 公式在平均角膜度数大于 46 度 (D) 的眼睛中的准确性:对平均角膜度数大于 46 D 的 101 名患者的 101 只眼睛进行了回顾性分析。计算了每个分析公式的平均绝对预测误差(MEA)、中位数绝对预测误差(MedEA)以及绝对屈光误差小于 0.25 D、0.50 D 和 1.00 D 的患者比例:Kane 公式的 MEA(0.53 ± 0.43)和 MedEA(0.41)最低,其次是 Barrett Universal II(MEA:0.56 ± 0.42,MedEA:0.49)、SRK-T(MEA:0.59 ± 0.44,MedEA:0.54)和 Haigis(MEA:0.77 ± 0.47,MedEA:0.69),结果显示差异显著。同时还观察到,凯恩公式的准确度最高,EA小于0.25 D、0.50 D和1.00 D的患者比例最高(分别为30.7%、54.4%和86.1%),而海吉斯公式的准确度最低(分别为12.9%、33.7%和69.3%):结论:对于平均角膜屈光度大于 46 D 的眼睛,Kane 公式被证明是计算人工晶体(IOL)功率的有用工具,与 Barrett Universal II、SRK-T 和 Haigis 公式相比,Kane 公式的精确度更高。
{"title":"Accuracy of intraocular lens power formulas in patients with average keratometry greater than 46 diopters","authors":"H. Rodríguez Ortiz ,&nbsp;L. Flores Ortiz ,&nbsp;R. Devereux García ,&nbsp;C. Palacio Pastrana ,&nbsp;M. Hilario Pérez ,&nbsp;G. Villanueva Pérez ,&nbsp;J.M. Piña Valdez ,&nbsp;G.Y. Montalvo Domínguez ,&nbsp;L.P. Gutierrez Díaz","doi":"10.1016/j.oftale.2024.07.006","DOIUrl":"10.1016/j.oftale.2024.07.006","url":null,"abstract":"<div><h3>Objective</h3><div>To compare the accuracy of Kane, Barrett Universal II, Haigis, and SRK-T formulas in eyes with average keratometry greater than 46 diopters (D).</div></div><div><h3>Methods</h3><div>A retrospective analysis was conducted on 101 eyes of 101 patients with average keratometry greater than 46 D. The absolute prediction error (EA) was obtained for each patient one month after surgery. The mean absolute prediction error (MEA), median absolute prediction error (MedEA) and the percentage of patients with absolute refractive error less than 0.25 D, 0.50 D, and 1.00 D were calculated for each formula analyzed.</div></div><div><h3>Results</h3><div>The Kane formula achieved the lowest MEA (0.53 ± 0.43) and the lowest MedEA (0.41), followed by Barrett Universal II (MEA: 0.56 ± 0.42, MedEA: 0.49), SRK-T (MEA: 0.59 ± 0.44, MedEA: 0.54), and Haigis (MEA: 0.77 ± 0.47, MedEA: 0.69), showing a significant difference in the results. It was also observed that the Kane formula was the most accurate, with the highest percentage of patients, with EA less than 0.25 D, 0.50 D, and 1.00 D (30.7%, 54.4%, and 86.1%, respectively), while the Haigis formula was the least accurate (12.9%, 33.7%, and 69.3%, respectively).</div></div><div><h3>Conclusion</h3><div>In eyes with corneas having average keratometry greater than 46 D, the Kane formula proves to be a useful tool in intraocular lens (IOL) power calculation and demonstrates higher precision compared to the Barrett Universal II, SRK-T, and Haigis formulas.</div></div>","PeriodicalId":93886,"journal":{"name":"Archivos de la Sociedad Espanola de Oftalmologia","volume":"99 10","pages":"Pages 413-419"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141725280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinal stroke: A call to action for awareness and treatment of ocular vascular emergencies 视网膜中风:认识和治疗眼部血管急症的行动呼吁。
Pub Date : 2024-09-01 DOI: 10.1016/j.oftale.2024.03.006
{"title":"Retinal stroke: A call to action for awareness and treatment of ocular vascular emergencies","authors":"","doi":"10.1016/j.oftale.2024.03.006","DOIUrl":"10.1016/j.oftale.2024.03.006","url":null,"abstract":"","PeriodicalId":93886,"journal":{"name":"Archivos de la Sociedad Espanola de Oftalmologia","volume":"99 9","pages":"Pages 363-364"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Andalusian Public Eye-Banks: a decade of continuous improvement 安达卢西亚公共眼库:持续改进的十年。
Pub Date : 2024-09-01 DOI: 10.1016/j.oftale.2024.05.011

Objectives

To show donation data, number of keratoplasties and the changes in transplant indications and techniques that occurred in Andalusia in the period from 2013 to 2022.

Materials and methods

The present work is a retrospective and descriptive study that included all keratoplasties performed between January 2013 and December 2022 in Andalusia, as well as the evolution of the cornea donation and transplant activity of the public and private hospitals pertaining to the waiting list management system of the Public Health System of Andalusia. Transplants performed in private centers with corneas from outside Andalusia were excluded.

Results

Cornea donation activity in Andalusia in the decade 2013−2022 has experienced a growth of more than 126%, while overall transplant activity has increased by 157% in public hospitals. Penetrating keratoplasty has decreased from 83% in 2013 to 43% in 2022, while lamellar techniques have increased from 17% to 57% in this same period. Since 2018, more lamellar transplants are performed than penetrating transplants. Regarding indications, endothelial conditions already represent the first cause of transplantation. In 2022 alone, the public Andalusian Eye Banks evaluated 1,054 corneas and prepared 281 endothelial grafts.

Conclusion

In the decade from 2013 to 2022 in Andalusia there has been an increase in donation activity and the number of keratoplasties. The public Eye Banks implementation in this period has played a key role in the widespread adoption of lamellar keratoplasty techniques and has enabled the transition to perform a greater number of lamellar keratoplasties compared to penetrating keratoplasty.

目的展示 2013 年至 2022 年期间安达卢西亚的捐赠数据、角膜移植数量以及移植适应症和技术的变化:本研究是一项回顾性和描述性研究,包括 2013 年 1 月至 2022 年 12 月期间在安达卢西亚进行的所有角膜移植手术,以及与安达卢西亚公共卫生系统候选名单管理系统相关的公立和私立医院角膜捐赠和移植活动的演变情况。结果显示,安达卢西亚地区的角膜捐献和移植手术数量均呈上升趋势:2013-2022年十年间,安达卢西亚的角膜捐献活动增长了126%以上,而公立医院的整体移植活动增长了157%。穿透性角膜移植术从2013年的83%下降到2022年的43%,而同期板层技术从17%上升到57%。自2018年以来,板层移植手术的数量多于穿透性移植手术。在适应症方面,内皮病变已经成为移植手术的首要原因。仅在2022年,安达卢西亚公共眼库就评估了1054个角膜,准备了281个内皮移植:结论:从 2013 年到 2022 年的十年间,安达卢西亚的捐赠活动和角膜移植手术数量都有所增加。在此期间,公共眼科银行的实施在广泛采用板层角膜移植技术方面发挥了关键作用,与穿透性角膜移植术相比,板层角膜移植术的实施数量更多。
{"title":"Andalusian Public Eye-Banks: a decade of continuous improvement","authors":"","doi":"10.1016/j.oftale.2024.05.011","DOIUrl":"10.1016/j.oftale.2024.05.011","url":null,"abstract":"<div><h3>Objectives</h3><p>To show donation data, number of keratoplasties and the changes in transplant indications and techniques that occurred in Andalusia in the period from 2013 to 2022.</p></div><div><h3>Materials and methods</h3><p>The present work is a retrospective and descriptive study that included all keratoplasties performed between January 2013 and December 2022 in Andalusia, as well as the evolution of the cornea donation and transplant activity of the public and private hospitals pertaining to the waiting list management system of the Public Health System of Andalusia. Transplants performed in private centers with corneas from outside Andalusia were excluded.</p></div><div><h3>Results</h3><p>Cornea donation activity in Andalusia in the decade 2013−2022 has experienced a growth of more than 126%, while overall transplant activity has increased by 157% in public hospitals. Penetrating keratoplasty has decreased from 83% in 2013 to 43% in 2022, while lamellar techniques have increased from 17% to 57% in this same period. Since 2018, more lamellar transplants are performed than penetrating transplants. Regarding indications, endothelial conditions already represent the first cause of transplantation. In 2022 alone, the public Andalusian Eye Banks evaluated 1,054 corneas and prepared 281 endothelial grafts.</p></div><div><h3>Conclusion</h3><p>In the decade from 2013 to 2022 in Andalusia there has been an increase in donation activity and the number of keratoplasties. The public Eye Banks implementation in this period has played a key role in the widespread adoption of lamellar keratoplasty techniques and has enabled the transition to perform a greater number of lamellar keratoplasties compared to penetrating keratoplasty.</p></div>","PeriodicalId":93886,"journal":{"name":"Archivos de la Sociedad Espanola de Oftalmologia","volume":"99 9","pages":"Pages 383-391"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experience with the use of intravitreal bevacizumab in cases with type I retinopathy of prematurity in a Latin American country 拉丁美洲某国在 I 型早产儿视网膜病变病例中使用玻璃体内贝伐单抗的经验。
Pub Date : 2024-09-01 DOI: 10.1016/j.oftale.2024.05.005

In retinopathy of prematurity (ROP) type I, the use of intravitreal bevacizumab (IVB), which is an inhibitor of endothelial growth factor (VEGF), has become popular despite not being a therapy approved by regulatory agencies. However, IVB has shown positive effects in halting disease progression at lower costs compared to other anti-VEGF therapies (ranibizumab or aflibercept). In this report, we present the experience during the treatment with IVB of 102 Colombian children with ROP type I, with a success rate of 98% (100). Complications occurred in 3.9% (4). Finally, we conclude that a single dose of IVB is an effective therapy for the management of ROP type I, with a lower risk of complications and retreatment.

在 I 型早产儿视网膜病变(ROP)中,玻璃体内贝伐单抗(IVB)是一种内皮生长因子(VEGF)抑制剂,尽管尚未获得监管机构的批准,但它的使用已变得非常普遍。然而,与其他抗血管内皮生长因子疗法(ranibizumab 或 aflibercept)相比,IVB 在阻止疾病进展方面已显示出积极的效果,而且成本更低。在本报告中,我们介绍了对 102 名哥伦比亚 I 型视网膜病变患儿进行 IVB 治疗的经验,成功率为 98%(100 例)。并发症发生率为 3.9%(4 例)。最后,我们得出结论:单剂量 IVB 是治疗 I 型视网膜病变的有效疗法,并发症和再治疗的风险较低。
{"title":"Experience with the use of intravitreal bevacizumab in cases with type I retinopathy of prematurity in a Latin American country","authors":"","doi":"10.1016/j.oftale.2024.05.005","DOIUrl":"10.1016/j.oftale.2024.05.005","url":null,"abstract":"<div><p><span>In retinopathy of prematurity (ROP) type I, the use of intravitreal </span>bevacizumab<span><span><span> (IVB), which is an inhibitor of endothelial growth factor (VEGF), has become popular despite not being a therapy approved by regulatory agencies. However, IVB has shown positive effects in halting </span>disease progression at lower costs compared to other anti-VEGF therapies (ranibizumab or aflibercept). In this report, we present the experience during the treatment with IVB of 102 Colombian children with ROP type I, with a success rate of 98% (100). Complications occurred in 3.9% (4). Finally, we conclude that a single dose of IVB is an effective therapy for the management of ROP type I, with a lower risk of complications and </span>retreatment.</span></p></div>","PeriodicalId":93886,"journal":{"name":"Archivos de la Sociedad Espanola de Oftalmologia","volume":"99 9","pages":"Pages 400-403"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141072339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Training in cataract surgery in Spain: analysis of the results of a survey of the European Board of Ophthalmology in a Spanish cohort 西班牙的白内障手术培训:欧洲眼科委员会对西班牙队列的调查结果分析。
Pub Date : 2024-09-01 DOI: 10.1016/j.oftale.2024.06.009

Introduction

A survey conducted by the European Board of Ophthalmology (EBO) revealed significant differences in the surgical training of the ophthalmology residents in Europe, including a disparity between the sexes and a variation in the experience on cataract surgery (CC) between them. This study is about the Spanish sub-cohort of the survey, and its objective is to present and analyse the peculiarities of ophthalmology training in Spain within the European context, as well as discussing ways to harmonise and improve that training throughout the EU.

Methods

We analyse data of the Spanish participants in the EBO exams, defining subgroups by the Autonomous Communities existing in Spain.

Results

93 of 135 requested participants (68.9%) responded. A 60.2% passed the EBO exam between 2021 and 2022, being mostly women (65.59%) aged 31 years old on average. The 91.4% were right-handed, coming from 13 of the 17 Spanish autonomous communities, although mostly from the Community of Valencia, Madrid and Catalonia. Respectively, 16.1%, 3.2% and 8.7% of the respondents said they have completed 10 or more training sessions on animal eyes, synthetic eyes and through the virtual reality simulator. This training was correlated with greater self-confidence in the management of a posterior capsular tear during surgery (p .025). All respondents manifested to have already performed stages of the CC. The average number of operations reported was 181.6 with regional disparities. A significant difference is observed between the sexes against women (−28.3%, p 0.03).

Discussion

Ophthalmologists in Spain, much more than other European countries, have greater opportunities for surgical training, with surgical procedures during the residency, that nearly triples those made by the others. Spanish women refer, like their European colleagues, to be in disadvantage in learning opportunities about cataract surgery. The Simulation Based Medical Education (SBME) allows to respond to the training deficit and complements the training on the patient. Although we demonstrate a significant correlation between the number of procedures carried out and self-confidence to operate simple cases, the SBME would be a complementary tool in self-confidence in front of a complication like capsular rupture.

Conclusion

Spain massively adopts the model named by us "surgery for all”, despite the underrepresentation of women in this area, emphasising a need for cultural change that the SBME could facilitate.

导言:欧洲眼科委员会(EBO)进行的一项调查显示,欧洲眼科住院医师的手术培训存在显著差异,包括性别差异和白内障手术(CC)经验差异。本研究的对象是该调查的西班牙分队,其目的是在欧洲范围内介绍和分析西班牙眼科培训的特殊性,并讨论如何协调和改善整个欧盟的眼科培训:我们分析了参加欧洲眼科医师资格考试(EBO)的西班牙学员的数据,并按西班牙现有的自治区进行了分组:结果:135 名应试者中有 93 人(68.9%)参加了考试。60.2%的人通过了 2021-2022 年间的 EBO 考试,其中大部分为女性(65.59%),平均年龄为 31 岁。91.4%的人是右撇子,来自西班牙 17 个自治区中的 13 个,但大部分来自巴伦西亚、马德里和加泰罗尼亚自治区。分别有 16.1%、3.2% 和 8.7% 的受访者表示,他们已经完成了 10 次或 10 次以上的动物眼睛、合成眼睛和虚拟现实模拟器培训。这种培训与在手术过程中处理后囊撕裂的自信心有关(p .025)。所有受访者都表示已经进行过几期 CC 手术。报告的平均手术次数为 181.6 次,各地区之间存在差异。讨论:西班牙的眼科医师在手术方面的经验与其他国家相比有什么不同?讨论:西班牙的眼科医生比其他欧洲国家的眼科医生有更多的机会接受手术培训,他们在实习期间的手术量几乎是其他国家的三倍。西班牙女医生与欧洲女医生一样,在学习白内障手术方面处于劣势。模拟医学教育(SBME)可以解决培训不足的问题,并对患者培训起到补充作用。尽管我们证明了手术次数与简单病例操作自信心之间存在明显的相关性,但SBME将是在囊膜破裂等并发症面前增强自信心的补充工具:西班牙大规模采用了我们命名为 "全民手术 "的模式,尽管女性在这一领域的代表性不足,但强调了文化变革的必要性,而 SBME 可以促进这种变革。
{"title":"Training in cataract surgery in Spain: analysis of the results of a survey of the European Board of Ophthalmology in a Spanish cohort","authors":"","doi":"10.1016/j.oftale.2024.06.009","DOIUrl":"10.1016/j.oftale.2024.06.009","url":null,"abstract":"<div><h3>Introduction</h3><p>A survey conducted by the European Board of Ophthalmology (EBO) revealed significant differences in the surgical training of the ophthalmology residents in Europe, including a disparity between the sexes and a variation in the experience on cataract surgery (CC) between them. This study is about the Spanish sub-cohort of the survey, and its objective is to present and analyse the peculiarities of ophthalmology training in Spain within the European context, as well as discussing ways to harmonise and improve that training throughout the EU.</p></div><div><h3>Methods</h3><p>We analyse data of the Spanish participants in the EBO exams, defining subgroups by the Autonomous Communities existing in Spain.</p></div><div><h3>Results</h3><p>93 of 135 requested participants (68.9%) responded. A 60.2% passed the EBO exam between 2021 and 2022, being mostly women (65.59%) aged 31 years old on average. The 91.4% were right-handed, coming from 13 of the 17 Spanish autonomous communities, although mostly from the Community of Valencia, Madrid and Catalonia. Respectively, 16.1%, 3.2% and 8.7% of the respondents said they have completed 10 or more training sessions on animal eyes, synthetic eyes and through the virtual reality simulator. This training was correlated with greater self-confidence in the management of a posterior capsular tear during surgery (p .025). All respondents manifested to have already performed stages of the CC. The average number of operations reported was 181.6 with regional disparities. A significant difference is observed between the sexes against women (−28.3%, p 0.03).</p></div><div><h3>Discussion</h3><p>Ophthalmologists in Spain, much more than other European countries, have greater opportunities for surgical training, with surgical procedures during the residency, that nearly triples those made by the others. Spanish women refer, like their European colleagues, to be in disadvantage in learning opportunities about cataract surgery. The Simulation Based Medical Education (SBME) allows to respond to the training deficit and complements the training on the patient. Although we demonstrate a significant correlation between the number of procedures carried out and self-confidence to operate simple cases, the SBME would be a complementary tool in self-confidence in front of a complication like capsular rupture.</p></div><div><h3>Conclusion</h3><p>Spain massively adopts the model named by us \"surgery for all”, despite the underrepresentation of women in this area, emphasising a need for cultural change that the SBME could facilitate.</p></div>","PeriodicalId":93886,"journal":{"name":"Archivos de la Sociedad Espanola de Oftalmologia","volume":"99 9","pages":"Pages 373-382"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2173579424001105/pdfft?md5=16b97d0f973ff2823d52afc82db920be&pid=1-s2.0-S2173579424001105-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Langerhans cell histiocytosis mimicking acute dacryocystitis 模仿急性泪囊炎的朗格汉斯细胞组织细胞增生症。
Pub Date : 2024-09-01 DOI: 10.1016/j.oftale.2024.06.003

Langerhans cell histiocytosis (LCH) is a myeloid neoplasm characterized by clonal neoplastic proliferation of Langerhans-type dendritic cells associated with an inflammatory infiltrate predominantly composed of lymphocytes and eosinophils. In this article, we present an unusual case of LCH with significant swelling in the left lacrimal sac region in a 3-year-old child, clinically mimicking acute dacryocystitis. Microscopically, it showed intense inflammatory infiltrate and histiocytes with irregular nuclei. The tumor cells were positive for S-100 protein, CD1a, and CD207 (langerin). Molecular study was positive for the V600E/E2/D mutation (EXON 15). This case emphasizes the importance of careful clinical, radiographic, and microscopic evaluation, as some neoplasms may mimic common benign lesions.

朗格汉斯细胞组织细胞增生症(Langerhans cell histiocytosis,LCH)是一种髓样肿瘤,其特征是朗格汉斯型树突状细胞的克隆性肿瘤性增生,并伴有主要由淋巴细胞和嗜酸性粒细胞组成的炎性浸润。本文介绍了一例不寻常的 LCH 病例,患者为一名 3 岁儿童,左侧泪囊区肿胀明显,临床症状类似急性泪囊炎。显微镜下,该病例表现为强烈的炎症浸润和核不规则的组织细胞。肿瘤细胞的 S-100 蛋白、CD1a 和 CD207(langerin)均呈阳性。分子研究显示,V600E/E2/D 突变(EXON 15)呈阳性。该病例强调了仔细进行临床、放射学和显微镜评估的重要性,因为有些肿瘤可能会模仿常见的良性病变。
{"title":"Langerhans cell histiocytosis mimicking acute dacryocystitis","authors":"","doi":"10.1016/j.oftale.2024.06.003","DOIUrl":"10.1016/j.oftale.2024.06.003","url":null,"abstract":"<div><p>Langerhans cell histiocytosis (LCH) is a myeloid neoplasm characterized by clonal neoplastic proliferation of Langerhans-type dendritic cells associated with an inflammatory infiltrate predominantly composed of lymphocytes and eosinophils. In this article, we present an unusual case of LCH with significant swelling in the left lacrimal sac region in a 3-year-old child, clinically mimicking acute dacryocystitis. Microscopically, it showed intense inflammatory infiltrate and histiocytes with irregular nuclei. The tumor cells were positive for S-100 protein, CD1a, and CD207 (langerin). Molecular study was positive for the V600E/E2/D mutation (EXON 15). This case emphasizes the importance of careful clinical, radiographic, and microscopic evaluation, as some neoplasms may mimic common benign lesions.</p></div>","PeriodicalId":93886,"journal":{"name":"Archivos de la Sociedad Espanola de Oftalmologia","volume":"99 9","pages":"Pages 404-407"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141433581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Woman with vigorexia experiencing severe bilateral vision loss 患有活力障碍的女性双侧视力严重下降。
Pub Date : 2024-09-01 DOI: 10.1016/j.oftale.2024.06.005

We describe a 28-year-old Caucasian female with vigorexy, who had no previous ocular history. She presented with bilateral gradual painless reduction in vision over the past 3 weeks. She had been taking niacin supplements, averaging 500 mg daily, for 7 years. Fundus examination revealed bilateral CME, which was confirmed by ocular coherence tomography scan. Fundus fluorescein angiography did not reveal any fluid leakage. Niacin supplementation was discontinued, and after 2 months, the CME had completely resolved, and the best corrected visual acuities improved to 1 in both eyes.

我们描述了一名 28 岁的白种女性,她患有眩晕症,以前没有眼科病史。她在过去 3 周内出现双侧视力逐渐下降,且无疼痛感。7 年来,她一直服用烟酸补充剂,平均每天 500 毫克。眼底检查显示双侧均有 CME,眼相干断层扫描证实了这一点。眼底荧光素血管造影检查未发现任何液体渗漏。停止补充烟酸两个月后,CME完全消退,双眼最佳矫正视力提高到1。
{"title":"Woman with vigorexia experiencing severe bilateral vision loss","authors":"","doi":"10.1016/j.oftale.2024.06.005","DOIUrl":"10.1016/j.oftale.2024.06.005","url":null,"abstract":"<div><p>We describe a 28-year-old Caucasian female with vigorexy, who had no previous ocular history. She presented with bilateral gradual painless reduction in vision over the past 3 weeks. She had been taking niacin<span> supplements, averaging 500 mg daily, for 7 years. Fundus examination revealed bilateral CME<span><span>, which was confirmed by ocular coherence tomography scan. </span>Fundus fluorescein angiography<span><span> did not reveal any fluid leakage. Niacin supplementation was discontinued, and after 2 months, the CME had completely resolved, and the </span>best corrected visual acuities improved to 1 in both eyes.</span></span></span></p></div>","PeriodicalId":93886,"journal":{"name":"Archivos de la Sociedad Espanola de Oftalmologia","volume":"99 9","pages":"Pages 408-411"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141433585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archivos de la Sociedad Espanola de Oftalmologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1